Bioventus Inc Revenue Growth Rates (BVS), Current and Historic Growth - CSIMarket
CSIMarket
 


Bioventus Inc   (NASDAQ: BVS)
 

BVS's Revenue Growth by Quarter and Year

Bioventus Inc 's Revenue results by quarter and year




BVS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 153.21
1st Quarter March 131.77
FY 284.98

BVSs Annual Revenue
Bioventus Inc 's Revenue in the fiscal year 2025 $ 567.16 millions
Bioventus Inc 's Revenue in the fiscal year 2024 $ 573.23 millions
Bioventus Inc 's Revenue in the fiscal year 2023 $ 512.19 millions
Bioventus Inc 's Revenue in the fiscal year 2022 $ 512.08 millions
Bioventus Inc 's Revenue in the fiscal year 2021 $ 430.90 millions




BVS Revenue second quarter 2026 Y/Y Growth Comment
Bioventus Inc reported Revenue growth of 3.76% year on year in the second quarter 2026, to $ 153.21 millions, this is lower than Bioventus Inc 's recent average Revenue increase of 13.27%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 119 other companies have achieved higher Revenue growth. While Bioventus Inc ' s Revenue increase of 3.76% ranks overall at the positon no. 2389 in the second quarter 2026.




BVS Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter December - 2.09 % 12.64 % 9.12 %
3rd Quarter September - -0.23 % 15.6 % -6.76 %
2nd Quarter June 3.76 % -1.98 % 10.67 % -2.53 %
1st Quarter March 7.08 % -4.88 % 8.8 % 1.9 %
FY   - -1.11 % 11.92 % -

Financial Statements
Bioventus Inc 's second quarter 2026 Revenue $ 153.21 millions BVS's Income Statement
Bioventus Inc 's second quarter 2025 Revenue $ 147.66 millions Quarterly BVS's Income Statement


BVS Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter December - 14.23 % 11.63 % 14.56 %
3rd Quarter September - -6.39 % -8.03 % -11.95 %
2nd Quarter June 16.27 % 19.99 % 16.43 % 14.46 %
1st Quarter March -16.55 % -20.43 % -5.77 % -5.49 %
FY (Year on Year)   - -1.11 % 11.92 % -




Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #120
Healthcare Sector #346
Overall #2389

Revenue Y/Y Growth Statistics
High Average Low
89.28 % 13.27 % -6.76 %
(Apr 02 2022)   (Sep 30 2023)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #120
Healthcare Sector #346
Overall #2389
Revenue Y/Y Growth Statistics
High Average Low
89.28 % 13.27 % -6.76 %
(Apr 02 2022)   (Sep 30 2023)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Bioventus Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
48.07 % 4.19 % -26.23 %
(Sep 26 2020)  


BVS's II. Quarter Q/Q Revenue Comment
Bioventus Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 16.27%, to $ 153.21 millions, from $131.77 millions in the first quarter.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Bioventus Inc 's Revenue growth quarter on quarter, overall rank is 604.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #111
Overall #604
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #111
Overall #604
Revenue Q/Q Growth Statistics
High Average Low
48.07 % 4.19 % -26.23 %
(Sep 26 2020)  


BVS's II. Quarter Q/Q Revenue Comment
Bioventus Inc achieved in the II. Quarter 2026 above company average sequential Revenue jump of 16.27%, to $ 153.21 millions, from $131.77 millions in the first quarter.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Bioventus Inc 's Revenue growth quarter on quarter, overall rank is 604.


Bioventus Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 27 2026)
12 Months Ending
(Mar 28 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 27 2025)
12 Months Ending
(Jun 28 2025)
Cumulative Revenue 12 Months Ending $ 581.11 $ 575.56 $ 566.85 $ 563.60 $ 563.92
Y / Y Revenue Growth (TTM) 3.05 % 1.53 % -1.11 % 1.39 % 4.98 %
Year on Year Revenue Growth Overall Ranking # 2059 # 1062 # 141 # 90 # 102
Seqeuential Revenue Change (TTM) 0.96 % 1.54 % 0.58 % -0.06 % -0.53 %
Seq. Revenue Growth (TTM) Overall Ranking # 2647 # 1879 # 1409 # 899 # 1947


Cumulative Revenue growth Comment
Although Bioventus Inc 's Annual Revenue growth year on year were below company's average 11.38% , Revenue announced in the Jun 27 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.05% year on year, from 1.53% in Mar 28 2026.

In the Healthcare sector 311 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1062 to 2059.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 140
Healthcare Sector # 312
Overall # 2059

Revenue TTM Y/Y Growth Statistics
High Average Low
43.64 %
11.38 %
-2.83 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 140
Sector # 382
S&P 500 # 2647
Cumulative Revenue growth Comment
Although Bioventus Inc 's Annual Revenue growth year on year were below company's average 11.38% , Revenue announced in the Jun 27 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3.05% year on year, from 1.53% in Mar 28 2026.

In the Healthcare sector 311 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1062 to 2059.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 140
Healthcare Sector # 312
Overall # 2059

Revenue TTM Y/Y Growth Statistics
High Average Low
43.64 %
11.38 %
-2.83 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 140
Sector # 382
S&P 500 # 2647




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BVS's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Jun 27 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 27 2026
Prestige Consumer Healthcare Inc 6.57%$ 6.569 millions
Msa Safety Inc6.25%$ 6.252 millions
Pacira Biosciences inc 6.24%$ 6.240 millions
Globus Medical Inc 5.94%$ 5.940 millions
Labcorp Holdings Inc 5.78%$ 5.778 millions
Tandem Diabetes Care Inc 5.77%$ 5.768 millions
Bristol myers Squibb Company5.74%$ 5.738 millions
Haemonetics Corporation5.65%$ 5.646 millions
Progyny Inc 5.58%$ 5.584 millions
Cytek Biosciences Inc 5.57%$ 5.566 millions
Amphastar Pharmaceuticals Inc 5.44%$ 5.441 millions
Becton Dickinson And Company5.44%$ 5.438 millions
Bruker Corporation5.22%$ 5.220 millions
Davita Inc 5.17%$ 5.165 millions
Park Dental Partners Inc 5.10%$ 5.102 millions
Lumexa Imaging Holdings Inc 5.08%$ 5.076 millions
Merck and Co Inc 5.07%$ 5.068 millions
Cv Sciences Inc 4.96%$ 4.958 millions
Viatris Inc 4.88%$ 4.877 millions
Fulgent Genetics Inc 4.86%$ 4.855 millions
Zimmer Biomet Holdings Inc 4.80%$ 4.799 millions
Mettler toledo International Inc 4.48%$ 4.485 millions
Phibro Animal Health Corporation4.40%$ 4.405 millions
Align Technology inc 4.35%$ 4.355 millions
Opko Health Inc 4.32%$ 4.319 millions
Dariohealth Corp 4.29%$ 4.291 millions
Orthofix Medical Inc 4.15%$ 4.147 millions
Pediatrix Medical Group Inc 4.04%$ 4.040 millions
Nrc Health3.98%$ 3.978 millions
Bioventus Inc 3.76%$ 3.757 millions


About Bioventus Inc Revenue Growth Rates (BVS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Bioventus Inc (CIK 1665988).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001665988-26-000042
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Bioventus Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.